Other highlights from the July 10 JNCI

ultidrug-resistant cells, compared with drug-sensitive cells. Blocking HDAC1 made the cells more sensitive to chemotherapy drugs that treat neuroblastoma.

This gene is of particular interest because [HDAC] inhibitors are a relatively new class of cancer chemotherapeutic agents undergoing preclinical testing for clinical development in the treatment of drug-resistant neuroblastoma, the authors write.

Contact: Steve Rutledge, director of communications, Childrens Hospital Los Angeles, srutledge@chla.usc.edu, (323) 361-4121

High Vitamin D Levels Are Associated with Reduced Colon Cancer Risk

A new study confirms an association between increased vitamin D levels and decreased risk of colon cancer.

Previous studies have shown that colon cancer mortality rates are lower in regions with greater sun exposure, which leads to vitamin D synthesis in the skin.

Kana Wu, M.D., Ph.D., of the Harvard School of Public Health in Boston and colleagues measured the levels of vitamin D in the blood plasma of 372 colorectal cancer patients and 739 controls. They used data from the Health Professionals Follow-up Study and the Nurses Health Study.

In the health professionals study, the researchers found an association between higher concentrations of vitamin D in patients plasma and reduced risk of colon cancer and colorectal cancer, though the latter link was not statistically significant. When combining data from both studies, the association held up for both colon and colorectal cancer.

In conclusion, our data provide additional support for an inverse association between vitamin D and colorectal and in particular colon cancer risk, the authors write.

Contact: Robin Herman, assistant dean of communications, Harvard School of Public Health, rherman@hsph.harvard.edu


Contact: Liz Savage
Journal of the National Cancer Institute

Page: 1 2

Related biology news :

1. Other highlights in the Aug. 7 JNCI
2. Other highlights in the July 24 JNCI
3. Other highlights in JNCI, June 26
4. Other highlights in JNCI, June 12
5. Other highlights from the June 6 JNCI
6. Other highlights in the May 16 JNCI
7. Other highlights from the April 18 Journal of the National Cancer Institute
8. Other highlights from the March 21 JNCI
9. Other highlights in the March 7 JNCI
10. Other highlights in the Feb. 21 JNCI
11. Other highlights in the Jan. 17 JNCI

Post Your Comments:

(Date:8/21/2019)... ... August 20, 2019 , ... ... second time since BioInformatics first fielded the survey in 2016. The results ... Experience , from BioInformatics, part of Science and Medicine Group. More than 800 ...
(Date:8/15/2019)... ... August 15, 2019 , ... Serialization deadlines in ... become increasingly complex, and aggregation becomes fully applied in the United States in ... long-term solution. , Until now, most regulations?including the Drug Supply Chain Security Act ...
(Date:8/14/2019)... LAKE CITY, and MARTINSRIED, Germany (PRWEB) , ... ... ... in high-throughput antibody screening and characterization, announced today that they have opened a ... Carterra’s platform has fueled the need for the new office. , The Munich ...
Breaking Biology News(10 mins):
(Date:8/4/2019)... ... ... Cirtec Medical Corporation, a strategic outsourcing partner for complex medical devices, including active ... 30,000 sq. ft. manufacturing facility in the Coyol free zone, located in Alajuela, ... expected to be fully operational by the end of the year, will be the ...
(Date:7/19/2019)... ... July 18, 2019 , ... World renowned two-time Everest summiter ... with California-based charity Coalition Duchenne for its 9th Annual Expedition Mt. Kinabalu in ... funding for Duchenne muscular dystrophy and was founded by Sabahan Catherine Jayasuriya. ...
(Date:7/9/2019)... ... , ... Today, at the BIO World Congress on Industrial Biotechnology ... announced the winners of the Consider Corn Challenge II. Three winners were chosen, each ... produce biobased materials. , “Corn is a sustainable, abundant and affordable industrial ...
(Date:6/18/2019)... , ... June 18, 2019 , ... Personalized Stem ... New Drug (IND) application to the FDA for use of a person’s own adipose-derived ... a treatment of osteoarthritis in the knee. This IND is the first of ...
Breaking Biology Technology:
Cached News: